Robert L. Rosiello's Net Worth
$3.16 Million
Who is Robert L. Rosiello?
Robert L. Rosiello has an estimated net worth of $3.16 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., Evelo Biosciences, Inc., and Axcella Health Inc..
SEC CIK
Robert L. Rosiello's CIK is 0001645041
Past Insider Trading and Trends
2015 was Robert L. Rosiello's most active year for acquiring shares with 7 total transactions. Robert L. Rosiello's most active month to acquire stocks was the month of June. 2016 was Robert L. Rosiello's most active year for disposing of shares, totalling 3 transactions. Robert L. Rosiello's most active month to dispose stocks was the month of July. 2015 saw Robert L. Rosiello paying a total of $5,001,845.29 for 449,550 shares, this is the most they've acquired in one year. In 2016 Robert L. Rosiello cashed out on 16,842 shares for a total of $313,885.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $8.115
EVP, Corp Dev & Strategy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.76% | -14.69K |
$18.00 | -$264,366.00 | 517.68K |
Dec 5
| |||
Form 4
| -0.15% | -817.00 |
$22.06 | -$18,023.02 | 532.37K |
Nov 4
| |||
Form 4
| -0.25% | -1.34K |
$23.54 | -$31,496.52 | 533.19K |
Aug 3
| |||
Form 4
| +18.90% | 84.97K |
—
|
—
| 534.52K |
May 12
| |||
Form 4
| +1.78% | 7.88K |
—
|
—
| 449.55K |
Oct 20
| |||
Form 4
| +1.82% | 7.88K |
$254.28 | $2,002,466.29 | 441.68K |
Jul 30 - Jul 31
| |||
Form 4
| +3.06% | 12.9K |
—
|
—
| 433.8K |
Jul 20
| |||
Form 4
| +3,162.79% | 408K |
—
|
—
| 420.9K |
Jul 1
| |||
Form 4
|
∞
| 12.9K |
$232.51 | $2,999,379.00 | 12.9K |
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) Snapshot price: $0.6664
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||